LONDON, August 21, 2014 – AstraZeneca and Mitsubishi Tanabe Pharma said on Wednesday they said signed a three-year research collaboration into diabetic nephropathy, or kidney failure due to diabetes.
The deal will focus on early-stage research and the hope is that by working together the companies will be able to identify promising drug candidates much faster than working alone.
There is no financial commitment for the research involved and each firm will contribute equal resources at their own cost.
Diabetes is a growing focus for many global drugmakers, reflecting the spread of the type 2 form of the disease, which is linked to obesity. Diabetic nephropathy occurs in up to half of patients who have diabetes for 20 years or more.Business Line
By Dr. C N Patil, HOD and Lead Consultant - Medical Oncology & Haemato-Oncology, Aster…
By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital …
Kurnool, November 20, 2024: Adoni, Andhra Pradesh, – The Khazi India Foundation is pleased to…
New Delhi, November 20, 2024: Aakash Healthcare marked this year’s Children’s Day with a joyful…
Dr Agarwals Eye Hospital, Bengaluru, is providing free consultations for diabetic patients aged 50 and…
By Ms. Archana S, Senior Nutritionist, Aster Whitefield Hospital, Bengaluru As an essential nutrient, protein…